Merck Unit Sues TriGen Over Folic Acid Patents

By Leigh Kamping-Carder (November 19, 2010, 4:18 PM EST) -- A Swiss affiliate of Merck KgaA and Pamlab LLC have accused TriGen Laboratories Inc. of falsely marketing two of its dietary supplement product lines as generic equivalents and infringing six patents covering a form of folic acid.

Pamlab and Merck & Cie filed a complaint Thursday in the U.S. District Court for the Eastern District of Louisiana, claiming that TriGen is selling knockoff dietary supplements that will confuse consumers.

Based in Covington, La., Pamlab specializes in prescription medical foods, including dietary products Neevo and Cerefolin, for individuals with problem pregnancies and early memory loss, respectively. Pamlab's products contain L-methylfolate, a special...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!